Leerink Swann downgraded Cadence Pharma (NASDAQ: CADX) from Outperform to Market Perform with a price target of $4.50 (from $5.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE